This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Review

. 2003 May;24(5):278-85.

doi: 10.1016/s1471-4906(03)00099-1.

Viral inhibition of MHC class II antigen presentation

Nagendra R Hegde¹, Mathieu S Chevalier, David C Johnson

Affiliations

PMID: 12738423
DOI: 10.1016/s1471-4906(03)00099-1

Review

Viral inhibition of MHC class II antigen presentation

Nagendra R Hegde et al. Trends Immunol. 2003 May.

. 2003 May;24(5):278-85.

doi: 10.1016/s1471-4906(03)00099-1.

Authors

Nagendra R Hegde¹, Mathieu S Chevalier, David C Johnson

Affiliation

¹ Department of Molecular Microbiology and Immunology, 3181 SW Sam Jackson Park Road, Oregon Health and Science University, Portland, OR 97239-3098, USA.

PMID: 12738423
DOI: 10.1016/s1471-4906(03)00099-1

No abstract available

PubMed Disclaimer

Similar articles

Molecular mechanisms of IFN-gamma to up-regulate MHC class I antigen processing and presentation.
Zhou F. Zhou F. Int Rev Immunol. 2009;28(3-4):239-60. doi: 10.1080/08830180902978120. Int Rev Immunol. 2009. PMID: 19811323 Review.
Loading of MHC class I and II presentation pathways by exogenous antigens: a quantitative in vivo comparison.
Storni T, Bachmann MF. Storni T, et al. J Immunol. 2004 May 15;172(10):6129-35. doi: 10.4049/jimmunol.172.10.6129. J Immunol. 2004. PMID: 15128799
Malignant glioma cells use MHC class II transactivator (CIITA) promoters III and IV to direct IFN-gamma-inducible CIITA expression and can function as nonprofessional antigen presenting cells in endocytic processing and CD4(+) T-cell activation.
Soos JM, Krieger JI, Stüve O, King CL, Patarroyo JC, Aldape K, Wosik K, Slavin AJ, Nelson PA, Antel JP, Zamvil SS. Soos JM, et al. Glia. 2001 Dec;36(3):391-405. doi: 10.1002/glia.1125. Glia. 2001. PMID: 11746775
Suppression of major histocompatibility complex class II-associated invariant chain enhances the potency of an HIV gp120 DNA vaccine.
Lu X, Wu S, Blackwell CE, Humphreys RE, von Hofe E, Xu M. Lu X, et al. Immunology. 2007 Feb;120(2):207-16. doi: 10.1111/j.1365-2567.2006.02492.x. Epub 2006 Nov 20. Immunology. 2007. PMID: 17116173 Free PMC article.
Molecular mechanisms of viral immune evasion proteins to inhibit MHC class I antigen processing and presentation.
Zhou F. Zhou F. Int Rev Immunol. 2009;28(5):376-93. doi: 10.1080/08830180903013034. Int Rev Immunol. 2009. PMID: 19811316 Review.

See all similar articles

Cited by

Giving CD4+ T cells the slip: viral interference with MHC class II-restricted antigen processing and presentation.
Forsyth KS, Eisenlohr LC. Forsyth KS, et al. Curr Opin Immunol. 2016 Jun;40:123-9. doi: 10.1016/j.coi.2016.03.003. Epub 2016 Apr 24. Curr Opin Immunol. 2016. PMID: 27115617 Free PMC article. Review.
Strong selection signatures for Aleutian disease tolerance acting on novel candidate genes linked to immune and cellular responses in American mink (Neogale vison).
Vahedi SM, Salek Ardestani S, Banabazi MH, Clark KF. Vahedi SM, et al. Sci Rep. 2024 Jan 10;14(1):1035. doi: 10.1038/s41598-023-51039-7. Sci Rep. 2024. PMID: 38200094 Free PMC article.
Antitumor efficacy of the Runx2-dendritic cell vaccine in triple-negative breast cancer in vitro.
Tang M, Liu Y, Zhang QC, Zhang P, Wu JK, Wang JN, Ruan Y, Huang Y. Tang M, et al. Oncol Lett. 2018 Sep;16(3):2813-2822. doi: 10.3892/ol.2018.9001. Epub 2018 Jun 21. Oncol Lett. 2018. PMID: 30127867 Free PMC article.
The role of type I interferon in the treatment of COVID-19.
Sodeifian F, Nikfarjam M, Kian N, Mohamed K, Rezaei N. Sodeifian F, et al. J Med Virol. 2022 Jan;94(1):63-81. doi: 10.1002/jmv.27317. Epub 2021 Sep 17. J Med Virol. 2022. PMID: 34468995 Free PMC article. Review.
Immune Response to SARS-CoV-2 Infection in Obesity and T2D: Literature Review.
Pérez-Galarza J, Prócel C, Cañadas C, Aguirre D, Pibaque R, Bedón R, Sempértegui F, Drexhage H, Baldeón L. Pérez-Galarza J, et al. Vaccines (Basel). 2021 Jan 29;9(2):102. doi: 10.3390/vaccines9020102. Vaccines (Basel). 2021. PMID: 33572702 Free PMC article. Review.

See all "Cited by" articles

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions

Grants and funding

LinkOut - more resources

Full Text Sources
- Elsevier Science
Research Materials
- NCI CPTC Antibody Characterization Program